Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-25 @ 1:26 AM
NCT ID:
NCT04624893
Eligibility Criteria:
Inclusion Criteria:
Hospitalized patients Patients who enrolled in the Pola CUP program and met the following criteria:
* Histologically confirmed DLBCL, patients have exhausted all therapeutic options for DLBCL and have been treated with at least two prior lines of therapy including R-CHOP (or similar regimen for 1L DLBCL)
* Not considered to be eligible for Bone Marrow Transplantation (BMT) (both allogenic or autologous)
* Have documented recent progression following or during last treatment, or became intolerant to the last treatment
* Does not have ≥ Grade 2 peripheral neuropathy(PN) prior to receiving Pola
* Patients treated with Pola-BR or Pola-R regimens
Exclusion Criteria:
* Patients participating in other clinical studies of Pola.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04624893
Study Brief:
Protocol Section:
NCT04624893